117 related articles for article (PubMed ID: 4585973)
1. Potential antileprotic agents. 2. Inhibition of mycobacterial dihydrofolic reductase.
DeGraw JI; Brown VH; Colwell WT; Morrison NE
J Med Chem; 1974 Jan; 17(1):144-6. PubMed ID: 4585973
[No Abstract] [Full Text] [Related]
2. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
Sirotnak FM
Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
[No Abstract] [Full Text] [Related]
3. Sequential blockade of the mycobacterial de novo folate pathway. A review.
Morrison NE
Int J Lepr Other Mycobact Dis; 1971; 39(1):34-43. PubMed ID: 4399473
[No Abstract] [Full Text] [Related]
4. Potential antileprotic agents. 3. Inhibition of mycobacterial dihydrofolic reductase by 2,4-diamino-5-methyl-6-alkylquinazolines.
DeGraw JI; Brown VH; Colwell WT
J Med Chem; 1974 Jul; 17(7):762-4. PubMed ID: 4209923
[No Abstract] [Full Text] [Related]
5. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
Jackson RC; Niethammer D; Hart LI
Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
[No Abstract] [Full Text] [Related]
6. Methotrexate analogs. 3. Synthesis and biological properties of some side-chain altered analogs.
Chaykovsky M; Rosowsky A; Papathanasopoulos N; Chen KK; Modest EJ; Kisliuk RL; Gaumont Y
J Med Chem; 1974 Nov; 17(11):1212-6. PubMed ID: 4213249
[No Abstract] [Full Text] [Related]
7. Accumulation of (3',5'-3H2)folic acid by human blood platelets. Effect of dihydrofolic acid reductase inhibitors.
Gaut ZN; Solomon HM; Baugh CM
Biochim Biophys Acta; 1970 Jul; 215(1):194-7. PubMed ID: 5494513
[No Abstract] [Full Text] [Related]
8. Dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to pyrimethamine, chlorguanide triazine, trimethoprim, and amethopterin.
Freisheim JH; Smith CC; Guzy PM
Arch Biochem Biophys; 1972 Jan; 148(1):1-9. PubMed ID: 5058682
[No Abstract] [Full Text] [Related]
9. Activity of sulfa drugs and dihydrofolate reductase inhibitors against Candida albicans.
Bush K; Freudenberger JS; Slusarchyk DS; Sykes RB; Meyers E
Experientia; 1982 Apr; 38(4):436-7. PubMed ID: 7044814
[TBL] [Abstract][Full Text] [Related]
10. Potential antileprotic agents. 1. Inhibition of a model mycobacterial system by diaryl sulfones.
Colwell WT; Chan G; Brown VH; DeGraw JI; Peters JH; Morrison NE
J Med Chem; 1974 Jan; 17(1):142-4. PubMed ID: 4585972
[No Abstract] [Full Text] [Related]
11. Absence of enhancing effect of trimethoprim on the activity of a sulfonamide against Mycobacterium leprae.
Pattyn SR; Verdoolaege-Van Loo G
Int J Lepr Other Mycobact Dis; 1972; 40(3):320. PubMed ID: 4574275
[No Abstract] [Full Text] [Related]
12. Dihydrofolate reductase from Trypanosoma equiperdum. I. Isolation, partial purification, and properties.
Jaffe JJ; McCormack JJ
Mol Pharmacol; 1967 Jul; 3(4):359-69. PubMed ID: 4382281
[No Abstract] [Full Text] [Related]
13. Studies on the mechanism of antifolate induced inhibition on HeLa cell growth.
Pristoupilová K; Hermanová E; Slavík K
Biochem Pharmacol; 1973 Aug; 22(15):1937-42. PubMed ID: 4722461
[No Abstract] [Full Text] [Related]
14. Effects of methotrexate and other antifolates on the growth and dihydrofolate reductase activity of Leishmania promastigotes.
Scott DA; Coombs GH; Sanderson BE
Biochem Pharmacol; 1987 Jun; 36(12):2043-5. PubMed ID: 3593407
[No Abstract] [Full Text] [Related]
15. Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues.
Stone SR; Morrison JF
Biochim Biophys Acta; 1986 Feb; 869(3):275-85. PubMed ID: 3511964
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of dihydrofolate reductase from Mycobacterium phlei.
Al-Rubeai M; Dale JW
Biochem J; 1986 Apr; 235(1):301-3. PubMed ID: 3741386
[TBL] [Abstract][Full Text] [Related]
17. Levels of dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to substituted pyrimidines, triazines and MTX.
Smith CC; Freisheim JH
Ann N Y Acad Sci; 1971 Nov; 186():182-4. PubMed ID: 5002296
[No Abstract] [Full Text] [Related]
18. Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase.
Ercikan E; Waltham M; Dicker A; Schweitzer B; Bertino JR
Adv Exp Med Biol; 1993; 338():515-9. PubMed ID: 8304170
[No Abstract] [Full Text] [Related]
19. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum.
Chen GX; Mueller C; Wendlinger M; Zolg JW
Mol Pharmacol; 1987 Apr; 31(4):430-7. PubMed ID: 3553892
[TBL] [Abstract][Full Text] [Related]
20. Folic acid antagonists. Methotrexate analogs containing spurious amino acids. Dichlorohomofolic acid.
Lee WW; Martinez AP; Goodman L
J Med Chem; 1974 Mar; 17(3):326-30. PubMed ID: 4811228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
